Your browser doesn't support javascript.
loading
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma.
Marin-Bejar, Oskar; Rogiers, Aljosja; Dewaele, Michael; Femel, Julia; Karras, Panagiotis; Pozniak, Joanna; Bervoets, Greet; Van Raemdonck, Nina; Pedri, Dennis; Swings, Toon; Demeulemeester, Jonas; Borght, Sara Vander; Lehnert, Stefan; Bosisio, Francesca; van den Oord, Joost J; Bempt, Isabelle Vanden; Lambrechts, Diether; Voet, Thierry; Bechter, Oliver; Rizos, Helen; Levesque, Mitchell P; Leucci, Eleonora; Lund, Amanda W; Rambow, Florian; Marine, Jean-Christophe.
Afiliación
  • Marin-Bejar O; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Rogiers A; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Dewaele M; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Femel J; Ronald O. Perelman Department of Dermatology and Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.
  • Karras P; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Pozniak J; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Bervoets G; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Van Raemdonck N; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Pedri D; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Swings T; VIB Technology Watch, Technology Innovation Lab, VIB, Leuven, Belgium.
  • Demeulemeester J; Laboratory of Reproductive Genomics, Department of Human Genetics, KU Leuven, Leuven, Belgium; Cancer Genomic Laboratory, The Francis Crick Institute, London, UK.
  • Borght SV; Department of Pathology, UZ Leuven, Leuven, Belgium.
  • Lehnert S; Center for Human Genetics, KULeuven, Leuven, Belgium.
  • Bosisio F; Laboratory of Translational Cell and Tissue Research, Department of Pathology, KU Leuven and UZ Leuven, Leuven, Belgium.
  • van den Oord JJ; Laboratory of Translational Cell and Tissue Research, Department of Pathology, KU Leuven and UZ Leuven, Leuven, Belgium.
  • Bempt IV; Center for Human Genetics, KULeuven, Leuven, Belgium.
  • Lambrechts D; Laboratory of Translational Genetics, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory of Translational Genetics, Center for Human Genetics, KU Leuven, Belgium.
  • Voet T; Laboratory of Reproductive Genomics, Department of Human Genetics, KU Leuven, Leuven, Belgium; KU Leuven Institute for Single Cell Omics, LISCO, KU Leuven, Leuven, Belgium.
  • Bechter O; Department of General Medical Oncology UZ Leuven, Belgium.
  • Rizos H; Macquarie University, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia.
  • Levesque MP; Department of Dermatology, University of Zürich Hospital, University of Zürich, Zürich, Switzerland.
  • Leucci E; Laboratory for RNA Cancer Biology, Department of Oncology, LKI, KU Leuven, Leuven, Belgium; Trace PDX Platform, Department of Oncology, LKI, KU Leuven, Leuven, Belgium.
  • Lund AW; Ronald O. Perelman Department of Dermatology and Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.
  • Rambow F; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: florian.rambow@kuleuven.be.
  • Marine JC; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: jeanchristophe.marine@kuleuven.be.
Cancer Cell ; 39(8): 1135-1149.e8, 2021 08 09.
Article en En | MEDLINE | ID: mdl-34143978
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Melanoma / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Melanoma / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Estados Unidos